Full-length human growth hormone affects almost every tissue in the body, promoting bone growth, increasing organ size, stimulating IGF-1 production, and altering glucose handling
The phase 3 FLOW trial evaluated Ozempic in patients with T2DM and chronic kidney disease (CKD)
The LDL receptor family includes the LDL receptor, LDLR-related protein 1 (LRP1), the very-low-density lipoprotein receptor (VLDLR), megalin (LRP2), LRP4, and LRP1b
GLP-1 RAs have been shown by Herman & Schmidt [1] to decrease nicotine-induced dopamine release in the nucleus accumbens, which attenuates the reinforcing effects of nicotine and may lessen cravings and the chance of relapse [1]
Whats next for GLP-1s in South Africa